Skip to main content

Table 3 Primary and secondary health outcome definition and measurment in the field study in the Parisan subway

From: Respiratory Disease Occupational Biomonitoring Collaborative Project (ROBoCoP): A longitudinal pilot study and implementation research in the Parisian transport company

Outcome

Measurement method

Diagnostic criteria

Chronic Obstructive Lung Disease

Spirometry performed by the trained occupational physician with the reversibility test if necessary

Post-bronchodilator forced expiratory volume in 1 s to the forced vital capacity (FEV1/FVC ratio) of less than 70% in presence of the clinical symptoms such as dyspnea, chronic cough or sputum production

Micronuclei frequency

Micronuclei counting (per 1000 cells (‰)) according to the standardized protocol (Buccal Cell Micronuclei Assay)

The individual measured values will be interpreted using a frequency diagram of micronuclei versus age in the healthy unexposed population (51). Values above reference values for a given age will be considered an early signal of the effect of genotoxic exposure

Asthma

Self-administered questionnaire

Being on treatment for asthma or at least one of the symptoms suggestive of asthma (asthma attack(s), wheezing in the chest, difficulty in breathing, attack of breathlessness) in the past 12 months

Chronic bronchitis

Self-administered questionnaire

Productive cough for at least 3 consecutive months per year and for at least 2 consecutive years or when the diagnosis has been confirmed by a physician

Emphysema

Self-administered questionnaire

Diagnosis has been confirmed by a physician

Active allergic rhinitis

Self-administered questionnaire

Symptomatic allergic rhinitis (sneezing or a runny or stuffy nose without having a cold or the flu) and under treatment during the last 12 months

Eczema

Self-administered questionnaire

Eczema diagnosis and/or treatment in the past 12 months

Atopy

Immediate reading allergic skin tests by the prick-test technique for 12 most common pneumallergens

The test results will be read by the occupational physician and considered positive if the diameter of the papule formed is greater than or equal to 3 mm and at least equal to half of the papule of the positive control (histamine)